Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.61 |
| ▸ | CNR1 | P21554 | 2/20 | 0.61 |
| ▸ | CNR2 | P34972 | 2/20 | 0.61 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | FAAH | O00519 | 1/20 | 0.46 |
| ▸ | F7 | P08709 | 2/20 | 0.43 |
| ▸ | F3 | P13726 | 2/20 | 0.43 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | OXER1 | Q8TDS5 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.43 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3690274 | 1.00 | ALDH1A1 (0.61) | ALDH1A1CNR1CNR2MAPTHPGD | |
| SCHEMBL3697326 | 0.98 | CNR1 (0.63) | ALDH1A1CNR1CNR2MAPTHPGD | |
| SCHEMBL4456390 | 0.88 | ALDH1A1 (0.53) | ALDH1A1CNR1CNR2MAPTHPGD | |
| SCHEMBL3688962 | 0.88 | ALDH1A1 (0.53) | ALDH1A1CNR1CNR2MAPTHPGD | |
| SCHEMBL3691941 | 0.88 | ALDH1A1 (0.55) | ALDH1A1CNR1CNR2MAPTHPGD | |
| SCHEMBL3691366 | 0.86 | ALDH1A1 (0.54) | ALDH1A1CNR1CNR2MAPTHPGD | |
| SCHEMBL3693540 | 0.83 | ALDH1A1 (0.50) | ALDH1A1CNR1CNR2MAPTHPGD | |
| SCHEMBL3695525 | 0.83 | ALDH1A1 (0.50) | ALDH1A1CNR1CNR2MAPTHPGD | |
| SCHEMBL10718626 | 0.82 | ALDH1A1 (0.65) | ALDH1A1CNR1CNR2MAPTHPGD | |
| SCHEMBL3688799 | 0.81 | ALDH1A1 (0.51) | ALDH1A1CNR1CNR2MAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100240616-A1 | NOVEL LIPID COMPOUNDS | PRONOVA BIOPHARMA NORGE AS (NO) | 2010-09-23 | — | — | US | disclosed |
| US-20100240616-A1 | NOVEL LIPID COMPOUNDS | PRONOVA BIOPHARMA NORGE AS (NO) | 2010-09-23 | — | — | US | disclosed |
| US-20100240616-A1 | NOVEL LIPID COMPOUNDS | PRONOVA BIOPHARMA NORGE AS (NO) | 2010-09-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100240616-A1 | NOVEL LIPID COMPOUNDS | ELOVL3, FFAR3, STARD3 | ALDH1A1 2317/4885CNR1 258/4885CNR2 131/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.